Agape ATP Corp

Name: Agape ATP Corp standardized financial statements, quarterly
Creator: Listed

ATPCNasdaqCIK 1713210HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.7k, Q2 FY2026

Operating income−$551.0k, Q2 FY2026

Net income$149.4k, Q2 FY2026

Agape ATP Corp, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	355	391	319	313	331	360	289	207	371	399	274	13.7
Cost of revenue	$k	121	138	115	119	147	182	133	142	131	165	114	1.9
Gross profit	$k	235	253	203	194	184	178	156	65.4	239	234	159	11.8
Selling, general and administrative	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$k	(317)	(1,016)	(724)	(454)	(548)	(848)	(720)	(622)	(601)	(1,298)	(677)	(551)
Income tax	$k	3.9	6.3	6.8	9.8	(2.9)	(8.9)	not reported	not reported	1.2	1.1	not reported	not reported
Net income	$k	(327)	(974)	(710)	(443)	(510)	(808)	(713)	(623)	(587)	(377)	(341)	149
Diluted EPS	$ per share	(0.09)	not reported	(0.18)	(0.12)	(0.13)	not reported	(3.63)	(0.62)	(0.01)	not reported	(0.33)	0.15
Basic EPS	$ per share	(0.09)	not reported	(0.18)	(0.12)	(0.13)	not reported	(3.63)	(0.62)	(0.01)	not reported	(0.33)	0.15

Balance sheet

Cash and equivalents$45.5k, Q2 FY2026

Shareholders' equity$22.1m, Q2 FY2026

Agape ATP Corp, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.3	4.8	3.6	3.2	2.7	2.0	0.6	0.2	0.1	0.1	0.2	0.0
Current assets	$m	0.5	5.2	4.3	3.8	3.4	2.8	24.8	24.3	24.1	24.3	24.7	24.8
Total assets	$m	1.7	5.7	4.8	4.3	4.0	3.2	25.2	24.6	24.4	24.6	24.9	25.0
Current liabilities	$m	1.0	1.1	0.8	0.8	0.9	1.1	1.0	1.2	1.5	2.1	2.7	2.9
Total liabilities	$m	1.2	1.4	1.1	1.0	1.2	1.3	1.2	1.3	1.6	2.2	2.8	3.0
Shareholders' equity	$m	0.4	4.4	3.7	3.2	2.7	1.9	24.0	23.4	22.8	22.5	22.1	22.1

Cash flow

Operating cash flow−$110.3k, Q2 FY2026

Capital expenditure$649, Q1 FY2025

Agape ATP Corp, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(254)	(1,006)	(1,243)	(413)	(425)	(645)	(1,454)	(494)	(257)	(208)	(395)	(110)
Capital expenditure	$k	not reported	not reported	not reported	not reported	not reported	not reported	0.6	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)1.00m, Q2 FY2026

Agape ATP Corp, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	75.5	75.5	75.5	3.8	3.9	3.8	3.9	0.2	1.0	50.0	1.0	1.0

Shares outstanding: 1.00m at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.